The omnibus also contains a number of new FDA policies — deemed the Food and Drug Omnibus Reform Act of 2022 — that were left off the FDA User Fee Reauthorization Act of 2022 earlier this year.
/PRNewswire/ Today, the U.S. Food and Drug Administration approved Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living.